Qingdao Vland Biotech Co Ltd (603739) — Cash Flow-to-Debt Ratio
Qingdao Vland Biotech Co Ltd (603739) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥24.29 Million could theoretically repay 0% of its total liabilities (CN¥1.14 Billion) in one year. See how financially flexible is Qingdao Vland Biotech Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Qingdao Vland Biotech Co Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Qingdao Vland Biotech Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see Qingdao Vland Biotech Co Ltd cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Qingdao Vland Biotech Co Ltd (2014–2024)
Year-by-year debt coverage analysis for Qingdao Vland Biotech Co Ltd. Check Qingdao Vland Biotech Co Ltd (603739) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥195.41 Million | CN¥1.11 Billion | ▲ +38.4% |
| 2023 | 0.13x | CN¥153.59 Million | CN¥1.21 Billion | ▲ +12.7% |
| 2022 | 0.11x | CN¥95.31 Million | CN¥844.93 Million | ▼ -32.4% |
| 2021 | 0.17x | CN¥89.51 Million | CN¥536.18 Million | ▼ -67.6% |
| 2020 | 0.51x | CN¥173.00 Million | CN¥336.22 Million | ▲ +96.1% |
| 2019 | 0.26x | CN¥65.33 Million | CN¥248.99 Million | ▼ -3.9% |
| 2018 | 0.27x | CN¥85.75 Million | CN¥313.94 Million | ▼ -34.8% |
| 2017 | 0.42x | CN¥121.90 Million | CN¥291.02 Million | ▼ -26.8% |
| 2016 | 0.57x | CN¥154.49 Million | CN¥269.96 Million | ▲ +132.9% |
| 2015 | 0.25x | CN¥74.27 Million | CN¥302.27 Million | ▲ +37.9% |
| 2014 | 0.18x | CN¥58.55 Million | CN¥328.53 Million | — |